KnowGovRepresentation. Influence. Action.
BillHR 5160 · 119

Stem Cell Therapeutic and Research Reauthorization Act of 2025

Introduced
Sep 4, 2025
Cosponsors
21
Traction
0
Last Action
May 21, 2026

Bill Summary

Reauthorizes funding for stem cell research and therapy programs. Extends existing programs to continue studying and developing stem cell treatments.

Sponsored By

Christopher H. Smith
Republican · New Jersey · House

Bill Journey

  1. Sep 4, 2025
  3. May 21, 2026You Are Here

    The committee will review the bill, debate amendments, and vote on whether to advance it to the full chamber.

  4. TBD

    The full chamber debates the bill, may amend it, and votes on whether to pass it.

  5. TBD

    If passed by the first chamber, the other chamber considers, may amend, and votes on the bill.

  6. TBD

    If passed by both chambers, the bill goes to the President to sign into law or veto.

Why It Matters

This bill affects patients with diseases or injuries that could be treated with stem cell therapies, as well as researchers and scientists working on stem cell projects, by providing continued funding for their work. It also impacts the biomedical industry by supporting the development of new stem cell-based treatments.

Impact Areas

Sample
Addresses Supply
Targets an underlying shortage driving costs.
Supports Families
Aimed at easing pressure on working households.
Long-term Impact
Effects compound across multiple budget cycles.
Expands Access
Lowers barriers for first-time participants.

Support & Opposition

Sponsor & cosponsor support by party
18backers
  • Democratic9
  • Republican9
Cross-party cosponsors9 · 53%

Documents

1

Full text opens on congress.gov, the official source.

Cosponsors (21)

Show all 13 more

4 more not shown here — see the full list on congress.gov.

Bill Details

Bill TypeHouse Bill · Federal
Primary TopicHealth
CommitteeHouse Committee (sample)Sample
IntroducedSep 4, 2025
Last UpdatedMay 21, 2026
Latest ActionOrdered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
Subjects
  • Health

Summary and impact analysis written by Judy (KnowGov's enrichment AI). Bill metadata, status, sponsor, and any floor votes from Prism. Sections marked “Sample” are placeholders not yet connected to live data.